Compositions and methods for use in targeting vascular destruction
CA 2541869 C · Owner: Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University · Inventors: Pero, Ronald W.; Sherris, David; Pettit, George R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A compound of Formula I below, a composition comprising the compound for treating a warm-blooded animal having a vascular proliferative disorder and use of an effective neoplastic disease inhibitory amount of the compound for inhibiting neoplastic disease in a patient. (see formula I) wherein: X represents a cis- or trans- alkenyl or alkanyl group represented by -(CH=CH)1- or -(CH2-CH2)1-; R1 R2, R3, and R4 are either H or Q+, and at least one of -OR1 -OR2, -OR3, or -OR4 is -O-Q+; and,wherein Q+ is piperazine or nicotinamide cation.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 16, 2000 and granted June 11, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 16, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 16, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.